首页 | 本学科首页   官方微博 | 高级检索  
     

脾虚证功能性消化不良大鼠胃窦平滑肌CNP-NPRB-cGMP通路改变及四君子汤的干预作用
引用本文:钟子劭,黄穗平,张望,林晓丰,钟日明,葛玉红,王静,叶振昊,张海燕. 脾虚证功能性消化不良大鼠胃窦平滑肌CNP-NPRB-cGMP通路改变及四君子汤的干预作用[J]. 中国实验方剂学杂志, 2017, 23(13): 133-137
作者姓名:钟子劭  黄穗平  张望  林晓丰  钟日明  葛玉红  王静  叶振昊  张海燕
作者单位:广州中医药大学 第二临床医学院, 广州 510006,广州中医药大学 第二临床医学院, 广州 510006;广东省中医院, 广州 510120,广东省中医院, 广州 510120,广东省中医院, 广州 510120,珠海市中西医结合医院, 广东 珠海 519020,广州中医药大学 第二临床医学院, 广州 510006,广东省中医院, 广州 510120,广东省中医院, 广州 510120,广东省中医院, 广州 510120
基金项目:国家自然科学基金项目(81373564,81302881);广东省自然科学基金项目(2015A030310389)
摘    要:目的:探讨脾虚证功能性消化不良的发病及四君子汤干预的作用机制。方法:将52只SD大鼠随机分为空白组、模型组、四君子汤组和莫沙必利组,采用碘乙酰胺灌服+小平台站立+饥饱失常法塑造脾虚证功能性消化不良动物模型,随后给予四君子汤6.3 g·kg~(-1)和莫沙必利0.45 mg·kg-1灌胃,每日灌胃给药1次,共14 d,检测大鼠胃排空率,采用酶联免疫吸附测定法(ELISA)检测血清C型钠尿肽(CNP)及胃窦平滑肌组织环磷酸鸟苷(cGMP)含量,蛋白质免疫印迹法(Western blot)检测胃平滑肌B型钠尿肽受体(NPRB)蛋白的表达。结果:与正常组比较,模型组大鼠体重、胃排空率明显下降(P0.05,P0.01),血清CNP含量,平滑肌NPRB蛋白的表达和c GMP含量升高(P0.05,P0.01);与模型组比较,四君子汤和莫沙必利干预后大鼠胃排空率升高(P0.05),血清CNP含量、平滑肌NPRB蛋白的表达量和c GMP含量降低(P0.05,P0.01)。结论:脾虚证功能性消化不良大鼠存在CNP-NPRB-c GMP信号通路改变,四君子汤可能通过调节该信号通路促进胃肠动力。

关 键 词:脾虚证  C型钠尿肽  胃平滑肌B型钠尿肽受体  四君子汤
收稿时间:2017-01-18

Disorder in CNP-NPRB-cGMP Pathway of Gastric Antral Smooth Muscle of Functional Dyspepsia Model Rats with Spleen-Deficiency Syndrome and Intervening Mechanism of Sijunzi Tang
ZHONG Zi-shao,HUANG Sui-ping,ZHANG Wang,LIN Xiao-feng,ZHONG Ri-ming,GE Yu-hong,WANG Jing,YE Zhen-hao and ZHANG Hai-yan. Disorder in CNP-NPRB-cGMP Pathway of Gastric Antral Smooth Muscle of Functional Dyspepsia Model Rats with Spleen-Deficiency Syndrome and Intervening Mechanism of Sijunzi Tang[J]. China Journal of Experimental Traditional Medical Formulae, 2017, 23(13): 133-137
Authors:ZHONG Zi-shao  HUANG Sui-ping  ZHANG Wang  LIN Xiao-feng  ZHONG Ri-ming  GE Yu-hong  WANG Jing  YE Zhen-hao  ZHANG Hai-yan
Affiliation:The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China,The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China;Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China,Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China,Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China,Zhuhai Hospital of Integrative Traditional Chinese and Western Medicine, Zhuhai 519020, China,The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou 510006, China,Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China,Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China and Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
Abstract:Objective: To investigate the pathogenesis of functional dyspepsia with spleen deficiency, and explore the intervening mechanism of Sijunzi Tang. Method: Fifty-two male SD rats were randomly divided into normal group, model group, Sijunzi Tang group and mosapride group. Iodoacetamide gavage method, small platform standing method and hunger disorder method were used to establish the functional dyspepsia rat model with spleen-deficiency. After modeling, Sijunzi Tang (6.3 g·kg-1) and mosapride (0.45 mg·kg-1) were given to each intervention group by gavage, once a day, for continuously 14 days. Gastric emptying rate, C-type natriuretic peptide(CNP) and cGMP content were detected by enzyme-linked immunosorbent assay(ELISA), and natriuretic peptide receptor type B(NPR-B) was determined by Western blot. Result: Compared with normal group, weight and gastric emptying rate were lower (P<0.05,P<0.01), CNP content in serum, NPR-B protein expression in gastric antrum smooth muscle, and cGMP content of gastric smooth muscle were higher in model group (P<0.05,P<0.01). Compared with model group, gastric emptying rate was higher (P<0.05), CNP content in serum, NPR-B protein expression in gastric antrum smooth muscle, cGMP content of gastric smooth muscle were lower in Sijunzi Tang group and mosapride group (P<0.05, P<0.01). Conclusion: Functional dyspepsia rats with spleen deficiency show CNP-NPRB-cGMP pathway disorder. Sijunzi Tang may improve gastrointestinal motility by regulating CNP-NPRB-cGMP pathway.
Keywords:spleen-deficiency syndrome  C-type natriuretic peptide(CNP)  natriuretic peptide receptor type B(NPR-B)  Sijunzi Tang
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号